FIELD: medicine.
SUBSTANCE: invention concerns preparation of peptide biologically active substances with activity of vascular endothelium growth factor (VEGF) with respect to angiogenesis stimulation, and can be used in medicine. In silico design is used for making oligopeptide of general formula I: A-X1-X2-X3-X4-X5-B (I) where A is Ac; X1 represents K or R; X2 represents either Q, or E, or N or D; X3 represents R or K; X4 represents either T, or F, or S, or L, or is absent, X5 represents To, or R, or is absent, and B represents OMe.
EFFECT: preparation of oligopeptides with VEGF activity, and extension of range of effective therapeutic agents that accelerates neogenesis.
4 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OLIGOPEPTIDE HAVING ACIDIC (aFGF) AND TRANSFORMING (TGF-β) GROWTH FACTOR ACTIVITY TOWARDS STIMULATION OF COLLAGEN BIOSYNTHESIS | 2008 |
|
RU2385873C2 |
| PEPTIDE SHOWING GROWTH STIMULATING ACTIVITY OF HEPATOCYTE GROWTH FACTOR (HGF) | 2009 |
|
RU2426740C1 |
| OLIGOPEPTIDE HAVING TRANSFORMATION GROWTH FACTOR (TGF-β) AND ONCOSTATIN M (OSM) TOWARDS FIBROBLAST PROLIFERATION | 2008 |
|
RU2385874C2 |
| OLIGOPEPTIDE HAVING CARTILAGE-DERIVED MORPHOGENETIC PROTEIN (CDMP-1) ACTIVITY ON CHONDROCYTE PROLIFERATION | 2009 |
|
RU2408603C1 |
| OLIGOPEPTIDE WITH STEM CELL FACTOR CSF ACTIVITY TOWARDS THYMOCYTE DIFFERENTIATION | 2008 |
|
RU2374262C1 |
| OPTIMIZED NUCLEOTIDE SEQUENCE AND PHARMACEUTICAL COMPOSITIONS BASED THEREON WITH SUSTAINED VEGF TRANSGENE EXPRESSION | 2015 |
|
RU2612497C2 |
| OLIGOPEPTIDE HAVING NEUREGULIN-1 ACTIVITY ON CARDIOMYOCYTE PROLIFERATION | 2010 |
|
RU2439078C1 |
| METHOD FOR PREDICTION OF DEVELOPING HAEMATOGENOUS METASTASES FOLLOWING COMBINED TREATMENT OF KIDNEY CANCER | 2013 |
|
RU2528100C1 |
| SOLID PHASE ENZYME-IMMUNOASSAY (ELIZA) FOR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) | 2007 |
|
RU2517301C2 |
| VEGF BINDING V9 NANOANTIBODY AND METHOD OF OBTAINING SAID ANTIBODY, V9-CODING NUCLEOTIDE SEQUENCE AND VECTOR CONTAINING SAID SEQUENCE, ENDOTHELIAL CELL PROLIFERATION INHIBITION METHOD | 2008 |
|
RU2395521C1 |
